NCT03677518 (MEDIAL-PIVOT) is a clinical trial in Arthroplasty Complications, sponsored by Centre Hospitalier Universitaire, Amiens.

Who is sponsoring NCT03677518?

NCT03677518 is sponsored by Centre Hospitalier Universitaire, Amiens.

What condition does NCT03677518 study?

NCT03677518 studies Arthroplasty Complications.

Is NCT03677518 still recruiting?

NCT03677518 is currently completed. Last updated 17 May 2023.

Last reviewed 2023-05-17 · How we verify

NCT03677518: MEDIAL-PIVOT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Total Knee Arthroplasty With the Medial-Pivot Knee System

Completed Last updated 17 May 2023

What this trial tests

trial in Arthroplasty Complications in 71 participants. Completed in 2 October 2017.

Timeline

1 January 2017

Primary endpoint
2 October 2017

2 October 2017

Quick facts

Lead sponsor	Centre Hospitalier Universitaire, Amiens
Status	Completed
Study type	OBSERVATIONAL
Enrollment	71
Start date	1 January 2017
Primary completion	2 October 2017
Estimated completion	2 October 2017

Conditions studied

Arthroplasty Complications — all drugs for Arthroplasty Complications →

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

18 and older, any sex, with Arthroplasty Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The "ball-in-socket" design of the Medial-Pivot knee system (MicroPort Orthopedics, Arling-ton, Tennessee, USA) aims to reproduce normal knee kinematics by medializing its rotational axis. Thegoal of this study was to measure knee range of motion (ROM) with this implant after a mean follow-up of 10 years and to report the survivorship and long-term clinical and radiological outcomes. Wehypothesized the prosthetic knee would have at least 120◦flexion at 10 years. This was retrospective, single-centre study of 74 Medial-Pivot knees implanted in71 patients (average age of 69 years) between May 2005 and November 2007. All patients who receiveda Medial-Pivot knee were included consecutively. The mean follow-up was 10 years. Clinical and radio-logical assessments were performed using the Knee Society Score (KSS) and Ewald's score. Kaplan-Meirsurvival analysis was used to calculate survivorship.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Arthroplasty Complications

Currently open trials in the same condition.

NCT06563531 — Are Elastic Restraints Still Necessary in Improved Rehabilitation Programs After Hip and Knee Prosthetic Surgery? · NA · recruiting
NCT06615739 — Comprehensive SRS Regenerex Tissue Attachment · active not recruiting
NCT06533020 — Long-term Outcomes of Complex Conversion Total Hip Arthroplasty · active not recruiting
NCT06527664 — Innovative Technologies for Salvage Procedures of Failed Treatments of Osteoarthritis: Biomimetics Solutions (CustomPN) · recruiting
NCT06025448 — Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability? · NA · recruiting

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
NCT07071662 — Induction of Labor in Breech Presentation · completed
NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03677518 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
Last refreshed: 17 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03677518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing